NCT02411123View on ClinicalTrials.gov

Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders

NACompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions

DepressionAnxiety

Interventions

GENETIC

IDgenetix Neuropsychiatric Test Panel

The IDgenetix Neuropsychiatric Test Panel is used to make recommendations on the medication therapy that might be impacted by the genetic background of the patient.

Trial Locations (1)

27609

Carolina Partners in Mental HealthCare, Raleigh